Europe — EMA
Oraverse (Phentolamine Mesilate)
Phentolamine mesylate, the active ingredient in Oraverse, is an alpha‑adrenergic antagonist presented as a sterile injectable solution for intravascular use.
Request sourcing
What is Phentolamine Mesilate?
Phentolamine mesylate, the active ingredient in Oraverse, is an alpha‑adrenergic antagonist presented as a sterile injectable solution for intravascular use. It is employed to manage certain vascular conditions and to reverse the effects of local anaesthetic agents in specific clinical situations. GNH USA supplies Oraverse as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.
GNH USA supplies Oraverse as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.
What is Phentolamine Mesilate used for?
Oraverse (phentolamine mesylate) acts on the alpha‑adrenergic system and is used in several vascular‑related indications.
- Management of severe hypertension during pheochromocytoma surgery: helps control sudden spikes in blood pressure. - Treatment of erectile dysfunction secondary to vasoconstriction: improves penile blood flow. - Reversal of local anaesthetic‑induced vasoconstriction: restores normal blood flow after dental procedures. - Management of peripheral ischemia in critical limb ischemia situations : facilitates blood flow restoration .
What are the side effects of Phentolamine Mesilate?
Phentolamine mesylate may exhibit several adverse reactions, most as
Common Side Effects: - S : t ... ... t ... - … g ... - ...
What precautions apply to Phentolamine Mesilate?
The g ... ... ....
What does Phentolamine Mesilate interact with?
The d ....
